The MAP2K4/JNK/c-Jun Signaling Pathway Plays A Key Role In Dexmedetomidine Protection Against Acetaminophen-Induced Liver Toxicity.
An-Hsun ChouChia-Chih LiaoHung-Chen LeeJiin-Tarng LiouFu-Chao LiuPublished in: Drug design, development and therapy (2019)
The data suggest that DEX likely downregulates the JNK signaling pathway and its downstream effectors to promote its hepatoprotective effect, providing a clinical application of DEX for the attenuation of PILT.